(Q28289119)

2

0 references

S Sánchez-Torres

3

0 references

E Farfan-García

4

0 references

R Mondragón-Lozano

5

0 references

R Pinto-Almazán

6

0 references

H Salgado-Ceballos

Oxidative stress in neurodegeneration: cause or consequence?

7

0 references

language of work or name

English

0 references

publication date

July 2013

0 references

published in

Free Radical Research

0 references

volume

47

0 references

issue

6-7

0 references

page(s)

451-62

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109/10715762.2013.795649

Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10715762.2013.795649

Methionine-35 of aβ(1-42): importance for oxidative stress in Alzheimer disease

21 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Lipid peroxides in the free radical pathophysiology of brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

An attempt at a rational classification of theories of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protein oxidation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative damage increases with age in a canine model of human brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Does oxidative damage to DNA increase with age?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Normal oxidative damage to mitochondrial and nuclear DNA is extensive

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Aging and protein oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative Stress, Redox Imbalance, and the Aging Process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The aging paradox: free radical theory of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Mitochondria, oxidants, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The aging brain: morphomolecular senescence of cortical circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Impact of aging on hippocampal function: plasticity, network dynamics, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Antioxidants may contribute in the fight against ageing: an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Proteasomal dysfunction: a common feature of neurodegenerative diseases? Implications for the environmental origins of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative and nitrative protein modifications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The impact of nutrition on cognition in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidants, antioxidants, and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The role of polyunsaturated fatty acids in restoring the aging neuronal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Essential fatty acids and the brain: possible health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Acute cognitive impairment in elderly ED patients: etiologies and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Cognitive impairment in elderly ED patients: need for multidimensional assessment for better management after discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Systemic infections and inflammation affect chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Can consuming flavonoids restore old microglia to their youthful state?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Clinical viral infections and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Structural and functional impact of the transgenic expression of cytokines in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The putative role of free radicals in the loss of neuronal functioning in senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Reduction of motor behavioral deficits in senescent animals via chronic prolactin administration. II. Non-stereotypic behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Chronic nimodipine treatment in aged rats: analysis of motor and cognitive effects and muscarinic-induced striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Psychomotor and spatial memory performance in aging male Fischer 344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Altered striatal dopaminergic and cholinergic reciprocal inhibitory control and motor behavioral decrements in senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Redox imbalance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Drug antioxidant effects. A basis for drug selection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Oxidants, oxidative stress and the biology of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Normal brain ageing: models and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

21 January 2018

Free radicals and aging.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Effects of Overexpression of Copper-Zinc and Manganese Superoxide Dismutases, Catalase, and Thioredoxin Reductase Genes on Longevity in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The biochemistry and medical significance of the flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Flavonoids as antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Cell culture protection and in vivo neuroprotective capacity of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Flavonoids: antioxidants or signalling molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

The future of neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Flavonoid intake and cognitive decline over a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protective effects of estradiol against amyloid beta protein-induced inhibition of neuronal Cl(-)-ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Corticosteroid receptors and neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

In vitro biological properties of flavonoid conjugates found in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuropharmacological effects of an ethanol extract of the Magnolia dealbata Zucc. leaves in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Honokiol, a multifunctional antiangiogenic and antitumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.795649